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Abstract
Background: Timely diagnosis and early initiation of life-saving antiretroviral therapy are critical factors in
preventing mortality among HIV-infected infants. However, resource-limited settings experience numerous
challenges associated with centralised laboratory-based testing, including low rates of testing, complex sample
referral pathways and unacceptably long turnaround times for results. Point-of-care (POC) HIV testing for HIVexposed infants can enable same-day communication of results and early treatment initiation for HIV-infected
infants. However, complex operational issues and service integration can limit utility and must be well understood
prior to implementation.
We explored and documented the challenges and enabling factors in implementing the POC Xpert® HIV-1 Qual
test (Cepheid, Sunnyvale, CA, USA) for early infant diagnosis (EID) as part of routine services in four public hospitals
in Myanmar.
Methods: This sub-study was part of a randomised controlled stepped-wedge trial (Australian and New Zealand
Clinical Trials Registry, number 12616000734460) designed to investigate the impact of POC testing for EID in
Myanmar and Papua New Guinea. Infants recruited during the intervention phase underwent POC testing at the
participating hospitals as part of routine care. Semi-structured interviews with 23 caregivers, 12 healthcare providers
and 10 key informants were used to explore experiences of POC-EID testing. The research team and hospital staff
documented and discussed implementation challenges throughout the study.

* Correspondence: Stanley.luchters@aku.edu
2
Burnet Institute, Melbourne, Australia
3
School of Public Health and Preventive Medicine, Monash University,
Melbourne, Australia
Full list of author information is available at the end of the article
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.

Yee et al. BMC Health Services Research

(2021) 21:863

Page 2 of 9

Results: Overall, caregivers and healthcare workers were satisfied with the short turnaround time of the POC test.
Occasional delays in POC testing were mostly attributable to late receipt of samples by laboratory technicians and
communication constraints among healthcare staff. Hospital staff valued technical assistance from the research
group and the National Health Laboratory. Despite staff shortages and infrastructure challenges such as unreliable
electricity supply and cramped space, healthcare workers and caregivers found the implementation of the POC test
to be feasible at pilot sites.
Conclusions: As plans for national scale-up evolve, there needs to be a continual focus on staff training,
communication pathways and infrastructure. Other models of care, such as allowing non-laboratory-trained
personnel to perform POC testing, and cost effectiveness should also be evaluated.
Keywords: Point-of-care, Early infant diagnosis, HIV, Viral load, GeneXpert, Prevention of mother-to-child
transmission, ART initiation, Implementation science, Myanmar

Contributions to the literature
 Point-of-care (POC) tests can improve rates of early

diagnosis of HIV in infants, but can be challenging
to implement in resource-limited settings
 POC implementation studies to date have occurred
in high-burden countries with high caseloads of
HIV-exposed infants; Myanmar’s facilities have low
caseloads so staff are less experienced in testing and
referral procedures, presenting new challenges
 This is the first study to show the feasibility of
implementation of POC HIV testing for infants in
routine healthcare services in a low-caseload
environment
 POC HIV early infant diagnosis testing was found to
be feasible and acceptable to both caregivers and
healthcare workers

Background
In 2017, an estimated 1.8 million children below 15 years
of age were living with HIV globally; 180,000 of whom
were newly infected [1]. Without antiretroviral treatment
(ART), half of all children with HIV die before they turn
2 years old, with as many as a third dying within the first
year of life [2–5]. Early diagnosis of HIV-infected infants
and initiation of ART is critical to reducing HIV related
morbidity and mortality. Despite World Health
Organization (WHO) recommendations that all HIVexposed infants receive a virological test (DNA or RNA)
by the age of 6 weeks (4–6 weeks) [6, 7], in 2016, less
than half (43%) of all infants born to HIV-positive
mothers worldwide were tested within this timeframe
[8]. In Myanmar, only 28% of exposed infants had HIV
testing before 2 months of age in 2017 [9, 10].
Myanmar has an estimated HIV prevalence of 0.7%
[11]. There were 11,000 children aged 0–14 living
with HIV, and less than 500 deaths due to AIDS
among children within the same age group [11]. Prevention of mother-to-child transmission of HIV

(PMTCT) programs have achieved coverage rates of 78%
of HIV-infected pregnant women, although localised evaluations have found that despite 88% of pregnant women
being initiated onto a regimen of antiretrovirals, only 59%
received ART for more than 8 weeks before delivery and
one in eight women did not receive any ART before delivery [12]. According to UNICEF, only about half of the
new-born (47%) received nevirapine syrup for prevention
of mother-to-child transmission [13], resulting in a vertical transmission rate of about 17% [11]. These figures
highlight the critical importance of a functional and effective early infant diagnosis (EID) testing and treatment program in reducing infant deaths. In one study, long test
result turnaround times (> 7 weeks) were documented for
36% of babies, with a further 33% never receiving their result, and this was worse for those living further from a
centralised laboratory [14]. Another evaluation indicated
that only 47% of babies received timely EID (before 8
weeks of age), with 27% experiencing a delay in sample
collection, and 26% never getting tested [15].
Many of the challenges associated with the effective
delivery of an EID program can be negated by
employing point-of-care (POC) technologies. These
molecular platforms are designed to be simple and
quick to operate in settings with only basic infrastructure and can eliminate sample transport issues and
reduce turnaround times, often permitting same-day
results. This can enable earlier ART initiation for
HIV-positive infants, improved linkage to care and reduced loss to follow-up [16–19]. To date, two POC
technologies have received WHO pre-qualification for
HIV infant diagnosis, the GeneXpert HIV-1 Qual
assay (Cepheid, Sunnyvale, CA, USA) and the Alere q
HIV-1/2 Detect (Alere Healthcare, Waltham, Massachusetts, USA). While they are not as simple as
lateral-flow HIV antibody diagnostic tests, these small
molecular testing platforms can diagnose HIV in less
than 2 h, and only require minimally trained
personnel, ambient room temperatures, reliable
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electricity supply, and effective waste disposal systems.
Many studies have assessed the feasibility and field
performance of these two POC technologies in the
EID context, reporting accurate performance compared to gold standard laboratory-based testing, and
high acceptability to health services and end users
[17, 20–23]. However, operational challenges – including those associated with the physical environment, staff time, supervision and monitoring,
engaging the manufacturer, and communicating results – have been observed [17, 18, 20–23].
It is important to note that implementation studies to
date have occurred in high-burden countries with significant caseloads of HIV-exposed infants (~ 23%) [17].
This contrasts with Myanmar, where there were an estimated 752 new HIV infections due to mother-to-child
transmission in 2017 [13] and most facilities have relatively low caseloads (2–7 cases per month) and thus
have less practice in testing procedures and referral
pathways. The implementation challenges and efficiencies of POC EID are likely to be significantly different
between low and high caseload settings.
Locally informed evidence is essential for key stakeholders and policy makers to inform the effective implementation and wider scale-up of POC testing in the EID
program in Myanmar to increase testing rates and improve linkage to care. This is the first study to assess the
implementation challenges and enabling factors associated with the introduction of the Xpert HIV-1 Qual test
in Myanmar’s public health system.
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reference laboratory). Hospitals were eligible for participation if they: i) offered antenatal HIV screening to
pregnant women, (ii) provided services for laboratorybased polymerase chain reaction tests for EID, (iii) had
an estimated caseload of at least three HIV-exposed infants attending each month; (iv) had the capacity, or potential capacity, to follow infants for at least 6 months
after delivery, and (v) had access to long-term HIV care
services, including ART, so that HIV-infected children
who met national criteria for treatment during the study
would have immediate and accelerated access to
treatment.
The participating hospital sites were South Okkalapa
Women’s and Children’s Hospital (200 beds), Central
Women’s Hospital (500 beds), Thanlyin General Hospital (200 beds) and Thingangyun General Hospital (800
beds). All four hospitals had PMTCT services integrated
into routine antenatal care services. Following delivery,
paediatric care is continued at the paediatric clinic of
each hospital.
Study participants
Caregivers

This qualitative field evaluation was part of a larger
multi-country cluster-randomised pragmatic steppedwedge trial (Australian and New Zealand Clinical Trials
Registry, number 12616000734460), which assessed the
effectiveness of implementing the POC Xpert® HIV-1
Qual assay for EID of HIV. In this design, the intervention EID test was introduced at each hospital in a randomised stepwise fashion until all hospitals were providing
the same POC service. Before commencing the intervention, each site had a one-month transition period, during
which no enrolment occurred and when staff were
trained, equipment was installed and participant flow
and logistics were organised. The study duration was 19
months, between October 2016 and June 2018, with participants enrolled over a 13-month period.

Most HIV-infected mothers were screened for study eligibility and recruited during their hospital stay following
childbirth, and additional recruitment took place with
caregivers during the infants’ follow-up visit to the
PMTCT clinic. Study staff explained the study to interested caregivers and obtained written informed consent
prior to enrolment.
Caregivers 18 years or older with a newborn infant
were eligible for participation in the study if: a) the parent/caregiver resided within the site-specific catchment
area and was willing to provide reliable contact information; b) infant(s) were born to confirmed HIV-infected
mothers and were within the first 28 days of life; c) the
parent/caregiver was able and willing to give informed
consent for enrolment of their infant in the study, and
permitted a member of the research team to remind
them to re-attend the clinic.
Near the end of the study, convenience sampling was
used to recruit participants who had received both
standard care and POC EID tests for qualitative interviews. Caregivers who had different experiences from
others in terms of repeated blood withdrawal, testing
and delayed receipt of results were also purposely invited
to participate in the interviews. In-depth interviews were
conducted with a total of 23 caregivers.

Study setting and sites

Healthcare workers and key informants

The study took place at four government hospitals in
and around Yangon, the biggest city and former capital
of Myanmar. The furthest hospital was located 20 km
from the National Health Laboratory (NHL – the

Hospital-based medico-social workers, laboratory technicians and paediatricians involved in the study implementation were invited to participate in qualitative
interviews, and all 12 invitees consented to participate.

Methods
Study design
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Ten key informants were also interviewed. These were
people who were knowledgeable and influential about
EID testing and HIV treatment from the four study hospitals, the National AIDS Program and the NHL.
Study procedures
Standard of care EID testing

We followed national standard operating procedures for
participants enrolled during the control and intervention
phases. Briefly, six dried blood spots were taken from
the heel or big toe of the infant, and in exceptional circumstances from venepuncture. Hospital staff transported the samples, usually the following day or after a
few days, to the NHL in Yangon, where they were tested
with the Abbott RealTime HIV-1 qualitative assay (Abbott, Abbott Park, Illinois, USA). At the same time, hospital staff collected the printed result forms of previously
tested samples from NHL. The results were then given
to the caregivers at their next follow-up appointment at
the hospital.
Intervention phase EID testing

In addition to the standard of care testing described
above, participants in the intervention phase were tested
with the Xpert HIV-1 Qual assay onsite at the hospital
laboratory and results integrated into routine services.
For this test, 200 μL of capillary or venous blood was
collected into EDTA tubes and a trained laboratory
technician from the hospital performed the test on the
same day, or the following day, depending on their
workload and availability. The paper-based Xpert HIV-1
Qual results were recorded and supplied to the consulting doctors or paediatricians and then provided to the
caregivers on the same day or at the scheduled appointment within a week if participants could not wait for the
results.
Data collection from caregivers and healthcare workers

Researchers who were not involved in the implementation of the trial conducted semi-structured interviews
with 23 caregivers (22 mothers and one aunt), 12 healthcare workers and 10 key informants to explore the feasibility and acceptability of the POC testing. The
interviews were guided by semi-structured interview
guides (see Additional files 1 and 2) developed particularly for this study and took between 45 min to 1 h. The
study procedures, risks and benefits were explained to
the participants and written informed consent was
obtained from all participants.
Implementation challenges were observed, and potential ways to overcome them proposed, and recorded in a
spreadsheet by the research coordinator throughout the
study period. Emerging challenges and alternative strategies were discussed with the study staff during the
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fortnightly monitoring visits with the research coordinator in order to refine the testing process.
Data management and analysis

Recordings of interviews with caregivers and healthcare
staff were transcribed and translated into English by the
qualitative researchers who conducted the interviews.
The research coordinator analysed the translated transcripts, using QSR International’s NVivo 12 qualitative
data analysis software (QSR International Pty Ltd., Melbourne, Australia). Both deductive and inductive analysis
methods were applied to identify themes within the data.
Themes derived from participant responses were crosschecked with the observed data recorded by the research
coordinator, and relevant quotes from participants were
extracted to support the themes of the observational
data and meeting notes.
In 2018, UNICEF outlined the key considerations for
introducing new POC diagnostic technologies into national health systems [24]. In analysing the results of our
study, we applied these key principles when comparing
the benefits and challenges of POC technologies compared with conventional laboratory systems. (outlined in
Table 1).
Ethics

Ethical approval was obtained from the Ethical Review
Committee of the Department of Medical Research (Ethics/DMR/2016/115) in Myanmar. In Australia, ethics approval was obtained from the Alfred Hospital Ethics
Committee (Project 500/14).

Results
This study identified the key factors in the successful implementation of POC testing for EID in four public hospitals in Myanmar. Note that a comparative analysis of
cost was beyond the scope of the study. Following the
UNICEF comparator framework, we will discuss our
results under the following themes: access, efficiency,
operability and infrastructure.
Access

Dedicated PMTCT clinics facilitated access to the Xpert
HIV-1 Qual assay. One site offered a dedicated clinic
once a week, two sites offered a clinic for HIV-positive
mothers once a month, and the fourth site had no set
PMTCT clinic dates. More frequent PMTCT clinics improved the efficiency of identification and enrolment of
infants requiring HIV testing and provision of test
results.
In the intervention phase, laboratory technicians usually performed the POC EID on the same day as the
doctor’s consultation, taking about 90 min to produce a
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Table 1 Summary of benefits and challenges of implementing Xpert®HIV-1 Qual at the hospital setting
Benefits

Challenges/Limitations

Access

• Specific PMTCT clinic day for HIV-infected mothers
• Shorter turnaround time (same-day results in some
study sites)
• Early receipt of results by patients

• Time constraint with PMTCT clinic opening hours in the afternoon
• Communication among multi-level healthcare staff required in the process
of testing and result return
• Logistical constraint (purchase of Xpert®HIV-1 Qual cartridges)

Efficiency

• Short testing time
• Low throughput of POC test (two samples can be run at a time although
• Early receipt of results by healthcare workers led to
instruments with higher capacity such as four-module device are available
early initiation of ART
• The distributor does not provide technical assistance in some locations
• A system for communicating EID testing and results to
patients by healthcare staff and among healthcare staff

Operability

• Workforce of medico-social workers was advantageous
for adherence counselling and patient follow-up
• Simple procedures of POC test
• Accessible refresher training and technical assistance

Infrastructure • Minimal requirement for a system for sample and
result transport

• Staff shortages and competing workloads
• Infrequent running of POC test
• Basic computer literacy
• Cramped space for staff and patients
• Irregular electricity supply

result. Caregivers generally waited at the hospital to receive the result on the same day.

site monitoring visits of the research coordinator and
developed communication pathways.

I was told that I would receive the result at 3:30 pm.
I am very pleased that my baby was tested and [I]
knew the result quickly. (Mother, lives in Thaketa)

No, they (HIV team) don’t give the request form to
us. If we can’t provide the form, [the laboratory technician] did not accept to do the test. The team did
not hand over the information to each other.
(Medico-social worker, male)

Same-day result delivery was acceptable to most caregivers, particularly considering the travel time experienced by some.
I came by bus since 9:30 am in the morning. The
bus took so long. So, I need to come 3 hours earlier
(laughing). When I arrived here it was 12:30 pm.
(Mother, lives in Dagon Satekan)
Results were not always returned on the same day and
39% (9/23) of the participating caregivers did not receive
the result on the testing day. Laboratory staff were
sometimes unable to test the EID sample upon receipt
due to competing urgent tasks or because some PMTCT
clinics ran late in the afternoon, with samples being received too close to closing time. To overcome this challenge, the healthcare providers encouraged the
caregivers with infants due to have EID testing to arrive
at the clinic early on that day so that the laboratory
received the samples in time.
We also identified additional challenges associated
with the existing EID system. While the integrated
healthcare service – made up of paediatricians and an
HIV team including a medical officer, nurse, counsellor
and laboratory technicians – provided comprehensive
care to HIV-infected mothers and their infants, there
were instances of delays in timely EID testing (both
standard of care and POC) and return of results owing
to poor communication within these structures. Healthcare providers were given a chance to discuss these communication gaps during the study staff meetings and the

Efficiency

Throughput of the Xpert POC EID test is limited by the
number of modules in the platform, which in the case of
this study, was two at each site. This reduced the number of tests that could be performed in one afternoon
session to a maximum of four and resulted in an inability to return results the same day for some participants.
“I arrived around one pm at the clinic and had the
blood sample taking quickly. The lab will be closed
at two pm and there were two patients ahead of me.
They asked me to come after three days (to take the
result). (Mother, lives in North Dagon)
Another limitation was that there was only one Cepheid
distributor of Xpert cartridges in Myanmar. In one instance, our most distant hospital experienced a breakdown of the machine, which then had to be moved to
the research office because the distributor did not provide technical assistance that far outside Yangon. The
ordering and receipt of Xpert HIV tests took 2–3
months, and the short expiry date of cartridges
(6 months at the time of the study), combined with a
low caseload, limited the ability to place large orders.
This resulted in frequent orders, requiring significant
human resources to place and follow up.
Smaller machine issues could be fixed by trained research staff. Staff involved in the implementation found
this to be an effective solution to the issues.
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If we had problem we called to Burnet [research
team] and asked how to solve it. Sometimes, the
error was encountered while the test is running for
about one hour. In that case, Burnet staff came to us
immediately and helped us. (Laboratory technician,
female)
Operability

The hospitals’ laboratory staff varied in qualifications
and capabilities. Medical technologists, with a four-year
training degree, generally took less time to become accustomed to the POC testing procedures, including
quality assurance and maintenance, than the less qualified laboratory technicians with diploma degrees. A lack
of experience in using computer technology made some
laboratory technicians less confident in handling the
Xpert testing device, particularly the linked laptop. This
challenge diminished over time with practice and by
pairing with other staff familiar with the technology.
Because I had to use the Xpert machine just once a
month, I sometimes forgot the procedure [computer
operation] so, I wrote down the operating steps in
my notes. Sometimes, I had to call [laboratory coordinator]. I also printed out the test procedure.
(Laboratory technician, female)
Overall, however, both medical technologists and less
qualified staff found the test acceptable and easy to use.
No difficulty. Fine. It is like a routine test for me. Not
complicated for me. (Laboratory technician, female)
Anyway, the test is simple so that it is feasible. No
special training needed for blood sample taking as
well as preparation of the sample using the test. The
important part is maintenance and care for the machine. The operators should be skilled for it. (Paediatrician, female)
Our study highlighted the critical importance of selecting the right human resources to support the implementation of POC testing. Medico-social workers, who
helped both patient care and the social aspects of caregivers and infants, were essential in minimising loss to
follow-up. They also facilitated communication between
patients and healthcare staff and played an important
role in the coordination of testing.
I asked the clients to inform me in advance when
they are coming for the test after their child turns
forty-five days. Then I can confirm with them [HIV
team] and the lab person if they are available.
(Medico-social worker, male)
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We did note that a shortage of staff, high workloads and
complex task-sharing were often associated with unclear
responsibilities regarding the POC testing and test result
delivery process. Laboratory staff highlighted concerns
about human resources in interviews.
It can be solved with increased human resource.
[laughs] My workload is a bit tight with the current
setting. Because I have both hospital workload and
the test with the study. (Laboratory technician,
female)
Infrastructure

The availability of the POC device reduced the complex
and sometimes ad hoc arrangements that were in place
for the delivery of dried blood spots to the NHL and the
collection of results.
[There is] no regular schedule for transporting samples to the National Health Laboratory ... three to
four samples were sent together. [There are] no
assigned staff for sample transport so it is random
and up to the chance of a person going to the [reference] laboratory. (Laboratory technician, female)
We just need to put the cartridge and the machine
runs itself. In the meantime, we can work for other
tasks. When it is ready, we just go to machine and
get the result. (Laboratory technician, female)
The POC device, the computer, and storage for the cartridges require considerable space. This was a major
issue at one study site which initially had to set the device up in its lunch room. The research coordinator had
several discussions with laboratory staff and a medical
superintendent until a proper and fixed place was
located for the device in the laboratory.
It (GeneXpert device) is close to our lunch table in
other side of the room, our meal at one side. We had
challenge in enough space to put the machine in, as
the rooms were a bit small. Now it has moved to another room. (Laboratory technician, female)
During the implementation of this study, the hospital
sites were not required to store more than 20 cartridges
onsite, because these could be provided regularly by the
study office. This reduced the amount of storage space
required at each test site, but this will need consideration if testing is scaled up.
Irregular electricity supply was a problem, and although steps were taken to negate this with the installation of an uninterruptible power source, voltage
variation caused problems in some test runs.
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I think it was because of the interrupted power supply. When the QC [Quality Control] was run, the
power was off. So, the QC didn’t work well. (Laboratory technician, female)

Discussion
This is the first study to investigate the implementation
of POC EID testing in routine services at public hospitals in Myanmar. Across these four pilot sites, POC HIV
EID testing was found to be feasible and acceptable to
both caregivers and healthcare workers. Implementation
was not without its challenges; infrastructure issues, the
need for continual training and developing an appropriate model of care and communication pathway were
highlighted.
Staff found the POC test simple, convenient and easy
to use. It circumvented many of the logistical challenges
associated with transporting samples and collecting results from the NHL. This finding is comparable to that
of a study in Cape Town where the providers considered
POC technology was simple and easy [21]. It, however,
introduced new challenges associated with clinic time
management, with some results not being returned on
the same day as the consultation because the blood samples were received too late in the day for processing or
the Xpert operator was not available. Approaches such
as clear communication channels and specifically scheduling appointments for HIV-exposed infants based on
the availability of the Xpert machine, operator and
healthcare worker need to be considered and structured
accordingly if testing is to be efficient. A study in South
Africa about HIV testing at point-of-care found that
maintaining relationships among healthcare providers
was critical to ensure sufficient stock of equipment and
test kits, good communication and to manage high
workload [20].
While all staff were trained in the operation of the
Xpert device, the low caseload of HIV-exposed infants at
each site limited the experience of each operator in conducting the test, and this was further complicated by the
need to operate a linked computer. High-quality and
clear standard operating procedures, frequent refresher
training, and a comprehensive quality system are critical
factors in ensuring competence. Similar to the findings
of a study in Zimbabwe [25], staff with basic computer
literacy quickly gained competency to operate the device.
For staff with little computer literacy working in a lowcaseload remote setting, a POC device with simpler procedures than the Xpert® HIV-1 Qual, such as the
GeneXpert Omni single-module device, is an alternative.
Infrastructure issues, predominantly reliable electricity
supply, were evident at these sites, and need considerable thought as the country considers scale-up of decentralised HIV testing. Additionally, space for the machine
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was a problem at one site in this study, although there
were no issues with the storage of test cartridges during
the pilot implementation. As McCann et al. [26] recommended to invest in POC EID rather than strengthening
the laboratory-based system, if Myanmar is to commit
to POC HIV EID testing, further consideration must be
given to an appropriate storage space at each site or the
development of a hub and spoke delivery system.
Accurate calculations of caseload per clinic and costs
data are essential in deciding on how to best distribute
resources in Myanmar, as are discussions with other
health programs, because the same Xpert machine can
be used for HIV viral load, hepatitis C diagnosis and
monitoring, human papillomavirus testing and tuberculosis testing and monitoring. As resources, workforce
and space are all limiting factors for the provision of
care in Myanmar, bringing these programs together and
using a hub-and-spoke model for sending samples from
sites with low caseload to sites with high caseload where
the POC machine is located [27] may add efficiencies to
the system in terms of optimising machine use, technical
expertise, maintenance and infrastructure support. This
will require utilization of the Xpert machine with modules appropriate for the caseload of the health facility in
order to avoid delays in result communication.
While our study provides information that is critical to
consider as POC EID testing is scaled up, it had some
limitations. The hospitals participating in this study were
all in the same region as the NHL. Their experiences of
sample transfer, results communication and access to
technical assistance with the NHL may differ from those
of more remote health facilities with greater geographical and transport challenges. Staff who operated the
Xpert machine in this study were all trained laboratory
personnel, and thus we are unable to extrapolate our results with respect to feasibility to non-laboratory staff.
Because this was part of a larger research study, dedicated research staff were available to assist with tracing
and following up patients and liaising with the Xpert incountry distributor for machine repair and procurement,
resources that will not be available upon national scaleup, suggesting our study overestimates the real-world
efficiency of POC testing.

Conclusion
Despite staff shortages and infrastructure challenges,
healthcare workers and caregivers found the implementation of the POC EID test feasible and acceptable. The
simplicity of the test required minimal supervision, and
access to the NHL was an advantage at the pilot sites.
The national scale-up strategy needs a continual focus
on staff training, communication pathways and infrastructure. Models of care involving non-laboratorytrained personnel performing POC testing and cost
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effectiveness of POC EID in low caseload settings should
also be evaluated.
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